The efficacy of piracetam in treating the sequelae of moderate and severe closed craniocerebral trauma (CCT) in adolescents was evaluated in studies of 42 patients aged 12–18 years who had suffered CCT 1.5–5 years prior to the study. Adolescents of the experimental group (20 individuals) received piracetam (Nootropil) at doses of 40–50 mg/kg (daily daily 1600–2400 mg) for one month; patients of group 2 (22 individuals) served as controls. Piracetam was found to have positive therapeutic effects on impairments to higher mental (memory, attention, executive) and motor (coordination) functions and on measures of the speeds of cognitive and motor operations.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
N. N. Zavadenko, A. S. Petrukhin, and T. V. Sokolova, “Characteristics of the long-term course of mild craniocerebral trauma in children. Questions of Diagnosis and treatment,” Vestn. Prakt. Nevrol., 3, 80–85 (1997).
N. N. Zavadenko, Hyperactivity and Attention Disorder in Childhood [in Russian], Moscow (2005).
G. V. Kovalev, Nootropic Substances [in Russian], Volgograd (1990).
A. N. Konovalov, L. B. Likhterman, and A. A. Potapova, Craniocerebral Trauma. A Clinical Handbook [in Russian], Moscow 2001, p. 2.
G. Craig, The Psychology of Development [Russian translation], St. Petersburg (2002), 7th Edition.
Yu. V. Mikadze and N. K. Korsakova, Neuropsychological Diagnosis and Correction in Young Schoolchildren [in Russian], Moscow (2001).
T. M. Achenbach, Manual for the Child Behavior Checklist, Burlington (1991).
M. B. Denckla, “Revised neurological examination for subtle signs,” Psychopharm. Bull., 21, 773–789 (1985).
R. K. Heaton, G. J. Chelune, L. J. Talley, et al., Wisconsin Card Sorting Test Manual (Revised and Expanded, Psychol. Ass. Resources Inc. (1999).
J. A. Langlois, W. Rutland-Brown, and K. E. Thomas, Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths, Atlanta, GA (2006), p. 55.
K. Leuner, “Pharmacological activities of piracetam and their extrapolated clinical potential,” in: Potential Treatments of the Many Facets of Cognitive Disorders, Athens (2007), pp. 32–35.
H. S. Levin, L. Ewing-Cobbs, and H. M. Eisenberg, “Neurobehavioral outcome in pediatric closed head injury,” in: Traumatic Brain Injury in Children, S. H. Broman and M. E. Michel (eds.), Oxford Press (1995), pp. 70–94.
H. Levin and S. Chapman, “Contribution of frontal lobe lesions to cognitive deficit after closed head injury in children,” in: Localisation of Brain Lesions and Developmental Functions, D. Riva and A. Benton (eds.), Pediat. Neurol. Ser. (Milan), 9, 97–108 (2000).
D. Mendelsohn, H. S. Levin, D. Bruce, et al., “Late MRI after head injury in children: relationship to clinical features and outcome,” Child’s Nervous System, 8, 445–452 (1992).
J. A. Middleton, “Practitioner review: Psychological sequelae of head injury in children and adolescents,” J. Child. Psychol. Psychiat., 42, 165–180 (2001).
T. W. Teasdale and A. W. Endberg, “Cognitive dysfunction in young men following head injury in childhood and adolescence: a population study,” J. Neurol. Neurosurg. Psychiat., 74, 933–936 (2003).
E. Walker, “Risk factors and the neurodevelopmental course of schizophrenia,” Eur. Psychiat., 7, Suppl. 4, 363–369 (2002).
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 108, No. 3, pp. 43–48, March, 2008.
About this article
Cite this article
Zavadenko, N.N., Guzilova, L.S. Sequelae of Closed Craniocerebral Trauma and the Efficacy of Piracetam in Its Treatment in Adolescents. Neurosci Behav Physi 39, 323–328 (2009). https://doi.org/10.1007/s11055-009-9146-2
- closed craniocerebral trauma
- long-term period
- piracetam (Nootropil)